These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 4376526
1. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus. Yang CS, Hewetson JF. Int J Cancer; 1974 Oct 15; 14(4):530-8. PubMed ID: 4376526 [No Abstract] [Full Text] [Related]
3. Specific neutralizing antibodies in Epstein-Barr virus associated diseases. Rocchi G, Hewetson J, Henle W. Int J Cancer; 1973 May 15; 11(3):637-47. PubMed ID: 4364719 [No Abstract] [Full Text] [Related]
4. Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Gerber P, Lucas S. Proc Soc Exp Biol Med; 1972 Nov 15; 141(2):431-8. PubMed ID: 4344263 [No Abstract] [Full Text] [Related]
5. Epstein-barr-virus nuclear antigen. Vonka V, Hirsch I. Prog Med Virol; 1982 Nov 15; 28():145-79. PubMed ID: 6283600 [No Abstract] [Full Text] [Related]
6. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Banatvala JE, Best JM, Waller DK. Lancet; 1972 Jun 03; 1(7762):1205-8. PubMed ID: 4113190 [No Abstract] [Full Text] [Related]
7. The role of Epstein-Barr virus (EBV) in various human disorders. Hewetson JF. South Med J; 1975 Oct 03; 68(10):1271-3. PubMed ID: 170689 [No Abstract] [Full Text] [Related]
9. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Klein G, Dombos L, Gothoskar B. Int J Cancer; 1972 Jul 15; 10(1):44-57. PubMed ID: 4122458 [No Abstract] [Full Text] [Related]
10. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Ida S, Sairenji T, Hinuma Y. Gan; 1972 Feb 15; 63(1):49-55. PubMed ID: 4339712 [No Abstract] [Full Text] [Related]
12. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases]. Gunven P. G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972 Jul 15; 65(9):228-32. PubMed ID: 4353758 [No Abstract] [Full Text] [Related]
13. Epstein-Barr virus in human disease. Langenhuysen MM, The TH. Neth J Med; 1973 Jul 15; 16(2):85-93. PubMed ID: 4350284 [No Abstract] [Full Text] [Related]
14. Epstein-Barr virus infections. Middleton PJ. Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535 [No Abstract] [Full Text] [Related]
15. [Present status of infectious mononucleosis and Epstein Barr virus]. Ducroix JP, Smail A, Vovan AT, Devauchelle B, Baillet J. LARC Med; 1984 Mar 05; 4(3):161-3. PubMed ID: 6325836 [No Abstract] [Full Text] [Related]
16. [Role of the Epstein-Barr virus in human pathology]. Rupniewska ZM. Acta Haematol Pol; 1979 Mar 05; 10(3):183-91. PubMed ID: 228518 [No Abstract] [Full Text] [Related]
18. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. Svedmyr A, Demissie A, Klein G, Clifford P. J Natl Cancer Inst; 1970 Mar 05; 44(3):595-610. PubMed ID: 11515428 [No Abstract] [Full Text] [Related]
19. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis. Greaves MF, Brown G. Clin Immunol Immunopathol; 1975 Mar 05; 3(4):514-24. PubMed ID: 163715 [No Abstract] [Full Text] [Related]
20. [Immunology of Epstein-Barr virus in lymphoproliferative diseases]. Bachmann AE, Giraudo Conesa LC, Braun M. Medicina (B Aires); 1974 Mar 05; 34(2):157-66. PubMed ID: 4368156 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]